Compound for the treatment of pemphigus vulgaris
The invention concerns a T-cell based immunotherapy using peptides which are derived from human membrane protein desmoglein. By applying a medical preparation including a peptide or a combination of peptides, a specific immunological tolerance is triggered. Therefore, the clinical signs of pemphigus vulgaris disease improve, because the base for disease is deprived.
Further information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
Media Contact
All latest news from the category: Technology Offerings
Newest articles
World’s smallest molecular machine
… reversible sliding motion in ammonium-linked ferrocene. Researchers stabilized ferrocene molecules on a flat substrate for the first time, creating an electronically controllable sliding molecular machine. Artificial molecular machines, nanoscale…
Towards the control of chemical reactions
Overcoming one of the challenges of quantum mechanics: A major result in quantum mechanics has been achieved: for the first time, the temporal evolution of a quantum system has been…
Planets form through domino effect
New radio astronomy observations of a planetary system in the process of forming show that once the first planets form close to the central star, these planets can help shepherd…